These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35142024)

  • 21. New drug treatment for Alzheimer's disease. Information from unpublished trials should be made available.
    Johnstone P
    BMJ; 1998 Oct; 317(7163):946. PubMed ID: 9841010
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug repositioning for Alzheimer's disease.
    Corbett A; Pickett J; Burns A; Corcoran J; Dunnett SB; Edison P; Hagan JJ; Holmes C; Jones E; Katona C; Kearns I; Kehoe P; Mudher A; Passmore A; Shepherd N; Walsh F; Ballard C
    Nat Rev Drug Discov; 2012 Nov; 11(11):833-46. PubMed ID: 23123941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herbal medicine in the treatment of Alzheimer's disease.
    Wu JG; Wang YY; Zhang ZL; Yu B
    Chin J Integr Med; 2015 Feb; 21(2):102-7. PubMed ID: 24752473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effectiveness of Vitamin E Treatment in Alzheimer's Disease.
    Lloret A; Esteve D; Monllor P; Cervera-Ferri A; Lloret A
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why are drug trials in Alzheimer's disease failing?
    Lancet; 2010 Aug; 376(9742):658. PubMed ID: 20801387
    [No Abstract]   [Full Text] [Related]  

  • 26. Alzheimer's disease failed clinical trials.
    Asher S; Priefer R
    Life Sci; 2022 Oct; 306():120861. PubMed ID: 35932841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapamycin and Alzheimer's disease: Time for a clinical trial?
    Kaeberlein M; Galvan V
    Sci Transl Med; 2019 Jan; 11(476):. PubMed ID: 30674654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why are drug trials in Alzheimer's disease failing?
    Smith AD
    Lancet; 2010 Oct; 376(9751):1466. PubMed ID: 21036274
    [No Abstract]   [Full Text] [Related]  

  • 29. Biomarkers in Alzheimer's disease drug development.
    Blennow K
    Nat Med; 2010 Nov; 16(11):1218-22. PubMed ID: 21052077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent developments in Alzheimer's disease therapeutics.
    Rafii MS; Aisen PS
    BMC Med; 2009 Feb; 7():7. PubMed ID: 19228370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selegiline for Alzheimer's disease.
    Birks J; Flicker L
    Cochrane Database Syst Rev; 2003; (1):CD000442. PubMed ID: 12535396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WITHDRAWN: Tacrine for Alzheimer's disease.
    Qizilbash N; Birks J; Lopez Arrieta J; Lewington S; Szeto S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD000202. PubMed ID: 17636619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tacrine for Alzheimer's disease.
    Qizilbash N; Birks J; López-Arrieta J; Lewington S; Szeto S
    Cochrane Database Syst Rev; 2000; 1999(2):CD000202. PubMed ID: 10796507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advancing Alzheimer's Disease Treatment: Lessons from CTAD 2018.
    Vellas B; Bain LJ; Touchon J; Aisen PS
    J Prev Alzheimers Dis; 2019; 6(3):198-203. PubMed ID: 31062835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta ; Birks J
    Cochrane Database Syst Rev; 2001; (1):CD000147. PubMed ID: 11279679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tacrine: first drug approved for Alzheimer's disease.
    Crismon ML
    Ann Pharmacother; 1994 Jun; 28(6):744-51. PubMed ID: 7919566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonsignificant weight gain with atypical antipsychotics in men with Alzheimer's Disease: an important result of the CATIE-Alzheimer's disease study.
    Bagepally BS; Prakash O
    Am J Psychiatry; 2009 Sep; 166(9):1063-4; author reply 1064-5. PubMed ID: 19723796
    [No Abstract]   [Full Text] [Related]  

  • 38. The Role of Clinical Trials in Preclinical Alzheimer's Disease Drug Development Programs.
    Cummings J
    J Prev Alzheimers Dis; 2020; 7(4):288-290. PubMed ID: 32920632
    [No Abstract]   [Full Text] [Related]  

  • 39. Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Yang G; Wang Y; Sun J; Zhang K; Liu J
    Curr Top Med Chem; 2016; 16(5):520-8. PubMed ID: 26268332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug use patterns of persons with Alzheimer's disease and related disorders living in the community.
    Semla TP; Cohen D; Paveza G; Eisdorfer C; Gorelick P; Luchins D; Hirschman R; Freels S; Levy P; Ashford JW
    J Am Geriatr Soc; 1993 Apr; 41(4):408-13. PubMed ID: 8463528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.